Drug profile · INN
sitagliptin phosphate anhydrous, metformin hydrochloride
SITAGLIPTIN AND METFORMIN HYDROCHLORIDE
sitagliptin phosphate anhydrous, metformin hydrochloride (SITAGLIPTIN AND METFORMIN HYDROCHLORIDE) is an FDA-listed pharmaceutical active ingredient. Current US regulatory status: approved.
Drug details — sitagliptin phosphate anhydrous, metformin hydrochloride
- US status
- approved
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.81
Quick answer
sitagliptin phosphate anhydrous, metformin hydrochloride (SITAGLIPTIN AND METFORMIN HYDROCHLORIDE) is an FDA-listed pharmaceutical active ingredient. Current US regulatory status: approved.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Frequently asked questions
What is sitagliptin phosphate anhydrous, metformin hydrochloride?
sitagliptin phosphate anhydrous, metformin hydrochloride (SITAGLIPTIN AND METFORMIN HYDROCHLORIDE) is an FDA-listed pharmaceutical active ingredient. Current US regulatory status: approved.
What is the brand name for sitagliptin phosphate anhydrous, metformin hydrochloride?
SITAGLIPTIN AND METFORMIN HYDROCHLORIDE is a marketed brand name for sitagliptin phosphate anhydrous, metformin hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of sitagliptin phosphate anhydrous, metformin hydrochloride?
sitagliptin phosphate anhydrous, metformin hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.